Dr. Erin R. Alesi
Claim this profileVirginia Commonwealth University/Massey Cancer Center
Area of expertise
Squamous Cell Carcinoma
Erin R. Alesi has run 7 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Lung Cancer
Erin R. Alesi has run 7 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Virginia Commonwealth University/Massey Cancer Center
VCU Massey Cancer Center At Stony Point
Clinical Trials Erin R. Alesi is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting
1 award
Phase 2
31 criteria
Cetuximab + Pembrolizumab
for Head and Neck Cancer
This phase III trial compares the effect of adding cetuximab to pembrolizumab versus pembrolizumab alone in treating patients with head and neck squamous cell carcinoma (HNSCC) that has come back after a period of improvement (recurrent) and/or that has spread from where it first started (primary site) to other places in the body (metastatic). Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Giving cetuximab and pembrolizumab together may be more effective at treating patients with recurrent and/or metastatic HNSCC than pembrolizumab alone.
Recruiting
2 awards
Phase 3
16 criteria
More about Erin R. Alesi
Clinical Trial Related
5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Erin R. Alesi has experience with
- Pembrolizumab
- Cisplatin
- Carboplatin
- Nivolumab
- Intensity-Modulated Radiation Therapy
- Pemetrexed
Breakdown of trials Erin R. Alesi has run
Squamous Cell Carcinoma
Lung Cancer
Oropharyngeal Carcinoma
Throat Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erin R. Alesi specialize in?
Erin R. Alesi focuses on Squamous Cell Carcinoma and Lung Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Erin R. Alesi currently recruiting for clinical trials?
Yes, Erin R. Alesi is currently recruiting for 5 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Erin R. Alesi has studied deeply?
Yes, Erin R. Alesi has studied treatments such as Pembrolizumab, Cisplatin, Carboplatin.
What is the best way to schedule an appointment with Erin R. Alesi?
Apply for one of the trials that Erin R. Alesi is conducting.
What is the office address of Erin R. Alesi?
The office of Erin R. Alesi is located at: Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University/Massey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.